Page 105 - WSAVA2018
P. 105

Suggested readings
American Animal Hospital Association. Canine vaccination guidelines. https://
Boscan P, Monnet E, Mama K, et al. Effect of maropitant, a neurokinin 1 receptor antagonist, on anesthetic requirements during noxious visceral stimulation of the ovary in dogs. Am J Vet Res. 2011;72:1576-1579.
Bragg RF1, Duffy AL, DeCecco FA, et al. Clinical evaluation of a single dose of immune plasma for treatment of canine parvovirus infection. J Am Vet Med Assoc. 2012;240:700-704.
Decaro N, Buonavoglia C. Canine parvovirus--a review of epidemiological and diagnostic aspects, with emphasis on type 2c. Vet Microbiol. 2012;155:1-12.
Forbes JM, Bell A, Twedt DC, Martin LE, Lappin MR, Mathis JC, Sullivan LA. Palatability assessment of an oral recuperation fluid in healthy dogs during the perioperative period. Top Companion Anim Med. 2015;30:35-38.
Gray LK et al: Comparison of two assays for detection of antibodies against canine parvovirus and canine distemper virus in dogs admitted to a Florida animal shelter, J Am Vet Med Assoc 240:1084, 2012.
Litster AL et al: Accuracy of a point-of-care ELISA test kit for predicting the presence of protective canine parvovirus and canine distemper virus antibody concentrations in dogs, Vet J Feb 28, 2012. [Epub ahead of print]
Hodge D 3rd, Delgado-Paredes C, Fleisher G. Intraosseous infusion flow rates in hypovolemic “pediatric” dogs. Ann Emerg Med. 1987;16:305-307.
Prittie J. Canine parvoviral enteritis: a review of diagnosis, management, and prevention: J Vet Emerg Crit Care 2004;4:167-176.
Reineke EL, Walton K, Otto CM. Evaluation of an oral electrolyte solution for treatment of mild to moderate dehydration in dogs with hemorrhagic diarrhea. J Am Vet Med Assoc. 2013;243:851-857.
Savigny MR, Macintire DK. Use of oseltamivir in the treatment of canine parvoviral enteritis. J Vet Emerg Crit Care (San Antonio). 2010;20:132-42.
Scherk MA, Ford RB, Gaskell RM, Hartmann K, Hurley KF, Lappin MR, Levy JK, Little SE, Nordone SK, Sparkes AH. 2013 AAFP Feline Vaccination Advisory Panel Report. J Feline Med Surg. 2013;15:785-808.
Tenne R, Sullivan LA, Contreras ET, Olea-Popelka F, Twedt DC, Fankhauser J, Mastrianna L, Lappin MR. Palatability and clinical effects of an oral recuperation fluid during the recovery of dogs with suspected parvoviral enteritis. Top Companion Anim Med 2016;31:68-72.
Venn EC, Preisner K, Boscan P, et al. Evaluation of an outpatient protocol in the treatment of canine parvoviral enteritis. J Vet Emerg Critical Care 2017;27:52–65.
Wilson S, Stirling C, Borowski S, et al. Vaccination of dogs with Duramune DAPPi+LC protects against pathogenic canine parvovirus type 2c challenge. Vet Rec. 2013;172:662.
Your Singapore, the Tropical Garden City
C. Cannon1, S. Ryan1
1University of Melbourne, U-Vet Animal Hospital, Melbourne, Australia
Claire Cannon BVSc (hons) DACVIM (Oncology) MANZCVS
Stewart Ryan BVSc (hons) MS DACVS MANZCVS University of Melbourne U-Vet Animal Hospital
Learning objective: Develop an approach to diagnosis of suspected soft tissue sarcomas in dogs and cats, including interpretation of histopathology reports. Understand the different possible surgical approaches, appropriate staging tests and indications for adjunctive treatments.
Soft tissue sarcoma (STS) is a generic term, encompassing a number of different mesenchymal tumour types. Generally, this term encompasses fibrosarcoma, peripheral nerve sheath tumour, myxosarcoma, perivascular wall tumour and liposarcoma. Tumours which are specifically excluded because
they have different presentations and/or behaviour
are muscle origin sarcomas, synovial sarcomas, haemangiosarcoma and lymphangiosarcoma.
Feline injection site sarcomas (FISS) are a specific subtype of soft tissue sarcoma characterised by history and location (growth at a site of previous injection), aggressive histologic features and often associated inflammation. Non-injection site related STS in cats should be managed as for canine STS, though evidence for prognostic factors such as grade and mitotic index is lacking.
Diagnosis for all soft tissue sarcomas typically requires histopathology. Cytology may be diagnostic or at
least suggestive, but especially for well-differentiated sarcomas, cannot reliably distinguish between neoplastic and reactive mesenchymal tissue. Cytology is recommended as a first step to rule out other possibilities e.g. mast cell tumour. Histopathology
may be obtained by incisional or excisional biopsy. In general, unless excision is achievable with wide margins, incisional biopsy for suspected soft tissue sarcomas should be performed to confirm the diagnosis and
grade to plan the most appropriate surgery. Revision surgeries for incomplete margins following excisional biopsy are typically more extensive than what would have been required had an appropriate first surgery

   103   104   105   106   107